Reviva Pharmaceuticals Holdings, Inc. (RVPH)
OTCMKTS · Delayed Price · Currency is USD
0.5510
-0.0333 (-5.70%)
At close: Jul 16, 2026

RVPH Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-16.63-19.86-29.92-39.26-28.26-8.52
Stock-Based Compensation
1.892.231.633.410.180.15
Other Adjustments
-0.03-0.09-0.720.240.19-1.59
Changes in Accounts Payable
-2.82-3.412.290.333.01-0.5
Changes in Accrued Expenses
-2.96-4-5.146.884.611.51
Changes in Other Operating Activities
0.340.54-1.690.071.31-1.71
Operating Cash Flow
-20.2-24.59-33.54-28.32-18.96-10.67
Short-Term Debt Issued
-0.410.980.67--
Short-Term Debt Repaid
-0.4-0.46-0.52-0.67--
Net Short-Term Debt Issued (Repaid)
-0.4-0.050.460--
Issuance of Common Stock
37.125.6123.1933.177.7931.6
Net Common Stock Issued (Repurchased)
37.125.6123.1933.177.7931.6
Financing Cash Flow
37.125.5623.6533.177.7931.6
Net Cash Flow
16.90.96-9.894.85-11.1720.93
Free Cash Flow
-20.2-24.59-33.54-28.32-18.96-10.67
Free Cash Flow Per Share
-4.23-6.78-19.88-23.80-19.43-14.43
Levered Free Cash Flow
-22.47-26.78-34-31.98-19.33-9.22
Unlevered Free Cash Flow
-22.39-27.09-35.36-32.24-19.28-10.81